![Iftach Seri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Iftach Seri currently works at CTS Ltd., as Chief Executive Officer from 2023 and Remedix Care Ltd., as Director from 2019.
Mr. Seri also formerly worked at Wavelength Pharmaceuticals Ltd., as Chief Executive Officer & Director from 2017 to 2022.
| Unternehmen | Position | Beginn |
|---|---|---|
Remedix Care Ltd.
 Remedix Care Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for hospitals | Direktor/Vorstandsmitglied | 01.09.2019 |
CTS Ltd.
 CTS Ltd. Medical DistributorsDistribution Services Distributes pharmaceutical, veterinarian and agriculture products | Vorstandsvorsitzender | 01.01.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Wavelength Pharmaceuticals Ltd.
 Wavelength Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets active pharmaceutical ingredients | Vorstandsvorsitzender | 01.12.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Wavelength Pharmaceuticals Ltd.
Wavelength Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets active pharmaceutical ingredients | Health Technology |
Remedix Care Ltd.
Remedix Care Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for hospitals | Health Technology |
CTS Ltd.
CTS Ltd. Medical DistributorsDistribution Services Distributes pharmaceutical, veterinarian and agriculture products | Distribution Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
